Lancor Scientific’s cancer screening tech to prove the global utility of the blockchain
Lancor Scientific’s cancer screening tech to prove the global utility of the blockchain

Lancor Scientific’s cancer screening tech to prove the global utility of the blockchain

By Eleonora Spagnolo - 21 Oct 2018

Chevron down

Lancor Scientific has launched a global cancer registry, using its blockchain for an early-detection cancer screening through the OMIS device.

The device has been developed to provide a more cost-effective, faster, secure and accurate cancer screening solution than current systems, adding also more types of cancer in 2019.

The blockchain is continuing to prove that it is an optimum solution to fast-track healthcare technologies worldwide.

The blockchain, in fact, is able to validate the screening devices, unlock the patient record, write the results to the registry, take payment for the cancer tests and provide real-time results.

Lancor Scientific also has its Medici Token that allows holders to purchase screening tests, addressing data security and fragmented records in healthcare, which can – of course – save lives.

 The OMIS device takes advantage of the photoelectric effect in quantum physics. When light is shone onto tissue, the magnetic component of the reflected light from the tissue can determine how malignant it is. This also means that the device does not subject the patient to potentially dangerous ultraviolet, X-ray or microwave radiation.

 Lancor Scientific is currently aiming to validate the OMIS device to screen for a range of cancers in the future.

Aamir Butt, CEO of Lancor Scientific, said: “Lancor Scientific has dedicated itself to making effective cancer screening available to everyone, everywhere. Our technology will help people to be screened earlier than ever before so that they can receive the necessary treatment, even before symptoms occur. Blockchain technology will provide a secure infrastructure to roll-out the device and Lancor Scientific platform. The fight against cancer is an uphill battle for everyone connected, so we hope that our solution can help people in the countries that need it the most. We are delighted to see continued progress towards this ultimate goal.”

Lancor Scientific’s advisory board includes Prof. Adenike Grange, ex-health Minister of Nigeria, who has consulted to the Federal Ministry of Health, UNICEF, UNFPA and more.

Eleonora Spagnolo

Journalist passionate about the web and the digital world. She graduated with honours in Multimedia Publishing at the University La Sapienza in Rome and completed a master's degree in Web and Social Media Marketing.

We use cookies to make sure you can have the best experience on our site. If you continue to use this site we will assume that you are happy with it.